Carbonic anhydrases 3-type

Btinzolamide Carbonic anhydrase type Azopt Suspension... 

Zonisamide is a broad-spectrum sulfonamide AED that blocks voltage-sensitive sodium channels by reducing voltage-dependent T-type Ca channels it also weakly inhibits carbonic anhydrase, and inhibits glutamate release. 

Part of the metabolic machinery of an osteoclast resembles the red cell and the renal tubule cells because all of these cell types contain the enzyme carbonic anhydrase (carbonate dehydratase) which generates acid, that is protons, and have ion pumps in their plasma membranes. The mechanism of bone resorption requires the action of cathepsin and metalloproteinase-9 working in an acidic environment (Figure 9.8). 

The fact that zinc is known to be a component of an enzyme carbonic anhydrase leaves no doubt as to its physiological significance. The amount of zinc in erythrocytes seems to parallel the carbonic anhydrase activity.21 The leucocytes which appear to lack carbonic anhydrase contain about 25 times as much zinc (per cell) as do the erythrocytes.20 It seems likely that an investigation of the zinc content of different types of white blood cells coupled with a study of individuals from the standpoint of the different types of white cells present (p. 35) would lead to the discovery of substantial inter-individual differences. The wide spread in the zinc concentrations in three human spleens has already been mentioned (p. 72). A recent study has been made of the intake and excretion of zinc by 13... 

Smith KS, Ferry JG. 1999. A plant-type (beta-class) carbonic anhydrase in the thermophilic vaethanoarchaeon Methanobacterium thermoautotrophicum. J Bacteriol 181 6247-53. 

Strop P, Smith KS, Iverson TM, et al. 2001. Crystal structure of the cab -type beta class carbonic anhydrase from the archaeon Methanobacterium thermoautotrophicum. J Biol Chem 276 10299-305. 

Acetazolamide is a carbonic anhydrase inhibitor that reduces aqueous humour production and is therefore indicated in glaucoma to reduce the intraocular pressure. Salbutamol is a selective, short-acting beta2-agonist used as a bronchodilator in asthma. Tolbutamide is a short-acting sulphonylurea used in type 2 (non-insulin dependent) diabetes mellitus. Chlorpromazine is an aliphatic neuroleptic antipsychotic drug used in schizophrenia. Zafirlukast is a leukotriene-receptor antagonist that is indicated in the prophylaxis of asthma but should not be used to relieve acute severe asthma. 

The results of kinetic and X-ray crystallographic experiments on mutant carbonic anhydrases II, in which side-chain alterations have been made at the residue comprising the base of the hydrophobic pocket (Val-143), illuminate the role of this pocket in enzyme-substrate association. Site-specific mutants in which smaller hydrophobic amino acids such as glycine, or slightly larger hydrophobic residues such as leucine or isoleucine, are substituted for Val-143 do not exhibit an appreciable change in CO2 hydrase activity relative to the wild-type enzyme however, a substitution to the bulky aromatic side chain of phenylalanine diminishes activity by a factor of about 10 , and a substitution to tyrosine results in a protein which displays activity diminished by a factor of about 10 (Fierke et o/., 1991). 

It is interesting that although the Val-143— His mutation leads to a bulky side chain at the base of the hydrophobic pocket, the mutant enzyme exhibits only a 10 -fold loss of CO2 hydrase activity relative to the wild-type enzyme (Fierke et ai, 1991). In this mutant the Val-I43- His side chain packs differently in the pocket relative to the side chains of the Val-143—>Phe and Val-143- Tyr mutants (Alexander et ai, 1991). It is likely that differences in side-chain packing, as well as differences involving active-site solvent structure, are responsible for differences in enzyme-substrate association behavior among the residue-143 mutants of carbonic anhydrase II. 

Several examples of non-oxicam-type 1,2-thiazine-containing small molecule enzyme inhibitors have been disclosed. The landmark work in this area involves the antiepileptic drug sulthiame 10, first discovered and approved for use over 30 years ago. Interest in this carbonic anhydrase inhibitor has been renewed by recent work on its efficacy in treatment of both childhood benign and focal epilepsies <2002MI469>. 

Thus although a protein can be made very specific for a particular metal, if it has a fold that generates matching properties to those possessed by the cation (e.g., carbonic anhydrase), this degree of matching is not required for the removal of heavy metals as they have such high binding constants to unconstrained sites. Clearly, there is a competition between two types of site for two metal ions ... 

Acetazolamide is a diuretic whose main action is the inhibition of carbonic anhydrase (see Chapter 15). Mild acidosis in the brain may be the mechanism by which the drug exerts its antiseizure activity alternatively, the depolarizing action of bicarbonate ions moving out of neurons via GABA receptor ion channels may be diminished by carbonic anhydrase inhibition. Acetazolamide has been used for all types of seizures but is severely limited by the rapid development of tolerance, with return of seizures usually within a few weeks. The drug may have a special role in epileptic women who experience seizure exacerbations at the time of menses seizure control may be improved and tolerance may not develop because the drug is not administered continuously. The usual dosage is approximately 10 mg/kg/d to a maximum of 1000 mg/d. 

There are several types of -class CAs i.e., a-CA I-VII, reported in the literature, out of which the human carbonic anhydrase II (HCA II), the most extensively studied carbonic anhydrase, has an exceptionally high CO2 hydration rate and a wide tissue distribution 107). The HCA II comprises a single polypeptide chain with a molecular mass of 29.3 kDa and contains one catalytic zinc ion, coordinated to three histidine residues, His 94, His 96, and His 119. A tetrahedral coordination geometry around the metal center is completed with a water molecule, which forms a hydroxide ion with a pK value of 7.0 108). Quigley and co-workers 109,110) reported that the inhibition of the synthesis of HCO3 from CO2 and OH- reduces aqueous humor formation and lowers intra-ocular pressure, which is a major risk factor for primary open-angle glaucoma. 

Carbonic anhydrase is a zinc(II) metalloenzyme which catalyzes the hydration and dehydration of carbon dioxide, C02+H20 H+ + HC03. 25 As a result there has been considerable interest in the metal ion-promoted hydration of carbonyl substrates as potential model systems for the enzyme. For example, Pocker and Meany519 studied the reversible hydration of 2- and 4-pyridinecarbaldehyde by carbonic anhydrase, zinc(II), cobalt(II), H20 and OH. The catalytic efficiency of bovine carbonic anhydrase is ca. 108 times greater than that of water for hydration of both 2- and 4-pyridinecarbaldehydes. Zinc(II) and cobalt(II) are ca. 107 times more effective than water for the hydration of 2-pyridinecarbaldehyde, but are much less effective with 4-pyridinecarbaldehyde. Presumably in the case of 2-pyridinecarbaldehyde complexes of type (166) are formed in solution. Polarization of the carbonyl group by the metal ion assists nucleophilic attack by water or hydroxide ion. Further studies of this reaction have been made,520,521 but the mechanistic details of the catalysis are unclear. Metal-bound nucleophiles (M—OH or M—OH2) could, for example, be involved in the catalysis. 

The most powerful and specific inhibitors of carbonic anhydrase are certain aromatic or heterocyclic sulfonamides containing an unsubstituted R—SO2NH2 group (28). Inhibitors of this type are of great value in biochemical and physiological studies of carbonic anhydrase action and have found some therapeutic applications (28). As the various factors involved in their interaction with the enzyme have been extensively discussed at a recent symposium (51, 52) they will only be briefly mentioned here. 

---